.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Baxter
Teva
Deloitte
Merck
Novartis
Fish and Richardson
Dow
Cipla
Covington

Generated: September 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: polymyxin b sulfate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
X Gen Pharms
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION063000ANDAX-GEN Pharmaceuticals, Inc.39822-0166-51 VIAL in 1 CARTON (39822-0166-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
X Gen Pharms
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION063000ANDAX-GEN Pharmaceuticals, Inc.39822-0166-71 VIAL in 1 CARTON (39822-0166-7) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Sagent Strides
POLYMYCIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION090110ANDASagent Pharmaceuticals25021-117-1010 VIAL in 1 CARTON (25021-117-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Gland Pharma Ltd
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION207322ANDABreckenridge Pharmaceutical, Inc.51991-939-1710 VIAL, SINGLE-USE in 1 CARTON (51991-939-17) > 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-USE (51991-939-99)
Gland Pharma Ltd
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION207322ANDAGland Pharma Limited68083-174-1010 VIAL in 1 CARTON (68083-174-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (68083-174-01)
Gland Pharma Ltd
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION207322ANDAAthenex Pharmaceutical Division, LLC.70860-103-1010 VIAL in 1 CARTON (70860-103-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Xellia Pharms Aps
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION202766ANDAX-GEN Pharmaceuticals, Inc.39822-0170-210 VIAL in 1 CARTON (39822-0170-2) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0170-1)
Xellia Pharms Aps
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION202766ANDAX-GEN Pharmaceuticals, Inc.39822-0171-710 VIAL in 1 CARTON (39822-0171-7) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0171-6)
Xellia Pharms Aps
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION202766ANDAXellia Pharmaceuticals ApS45932-0030-110 VIAL in 1 CARTON (45932-0030-1) > 1 INJECTION in 1 VIAL
Xellia Pharms Aps
POLYMYXIN B SULFATE
polymyxin b sulfate
INJECTABLE;INJECTION202766ANDAFresenius Kabi USA, LLC63323-367-1110 VIAL in 1 CARTON (63323-367-11) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Medtronic
Moodys
Novartis
Cerilliant
Harvard Business School
US Department of Justice
Dow
AstraZeneca
Covington

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot